Firmenbeschreibung
Gilead Sciences Inc. ist ein unabhängiges und weltweit operierendes Biotechnologie-Unternehmen. Kernkompetenz ist die Entwicklung von therapeutischen Lösungen für die Behandlung von lebensbedrohlichen Infektionskrankheiten. Dabei konzentriert sich Gilead Sciences insbesondere auf systemische Pilzinfektionen, Tumorerkrankungen, HIV und Hepatitis-B. Die Arzneimittel enthalten hauptsächlich Wirkstoffe, die im eigenen Haus entwickelt wurden. Mit der Übernahme der Biotechfirma Pharmasset hat sich Gilead verschiedene aussichtsreiche Medikamente für die Behandlung von Leberentzündungen (Hepatitis C) gesichert.
KeyData
| endOfFinancialYear: | 31.12.2024 00:00 |
| stockholderStructure: | BlackRock Inc. (9.85614%),Vanguard Group (8.97557%),Capital World Investors (6.69133%),CAPITAL RESEARCH GLOBAL INVESTOR (4.78846%),State Street Corporation (4.77877%),Dodge & Cox (2.67247%),GEODE CAPITAL MANAGEMENT LLC (2.02866%),Wellington Management Group (1.49537%),Morgan Stanley (1.42888%),FMR LLC. (1.37236%) |
| sharesOutstanding: | 1245346062.0000 |
| ceo: | Daniel O’Day |
| board: | Andrew Dickinson, Jyoti Mehra, Stacey Ma, Flavius Martin, Johanna Mercier, Cindy Perettie, Deborah H. Telman, Merdad Parsey |
| supervisoryBoard: | Daniel O’Day, Jacqueline K. Barton, Jeffrey A. Bluestone, Sandra J. Horning, Kelly A. Kramer, Harish Manwani, Anthony Welters, Ted W. Love, Javier J. Rodriguez |
| countryID: | 20 |
| freeFloat: | 99.8900 |
| faceValue: | 0.0010 |
| faceValueCurrencyID: | 4 |
| faceValueCurrency: | USD |
| sectorName: | Pharmazeutische Industrie |
| industryName: | Gesundheitswesen |
| subsectorName: | Pharmazeutische Industrie |
| country: | USA |
| countryName: | USA |
Kontakt
| name: | Jacquie Ross |
| phone: | +1-650-524-7792 |
| email: | investor_relations@gilead.com |
| irWebSite: | https://investors.gilead.com/ |
Adresse
| street: | 333 Lakeside Drive |
| city: | Foster City, California 94404, USA |
| phone: | +1-650-574-3000 |
| fax: | +1-650-578-9264 |
| webSite: | www.gilead.com |
| email: | corporate_development@gilead.com |
Finanzen (kurz)
| year: | 2022 | cash: | 5412.0000 |
| balanceSheetTotal: | 63171.0000 | liabilities: | 41962.0000 |
| shareCapital: | 1.0000 | totalShareholdersEquity: | 21209.0000 |
| sales: | 27281.0000 | incomeBeforeTaxes: | 5814.0000 |
| netIncome: | 4592.0000 | cashFlow: | 74.0000 |
| currencyID: | 4 | units: | 1000000 |
| currency: | USD |
| year: | 2023 | cash: | 6085.0000 |
| balanceSheetTotal: | 62125.0000 | liabilities: | 39376.0000 |
| shareCapital: | 1.0000 | totalShareholdersEquity: | 22749.0000 |
| sales: | 27116.0000 | incomeBeforeTaxes: | 6859.0000 |
| netIncome: | 5665.0000 | cashFlow: | 673.0000 |
| currencyID: | 4 | units: | 1000000 |
| currency: | USD |
| year: | 2024 | cash: | 9991.0000 |
| balanceSheetTotal: | 58995.0000 | liabilities: | 39749.0000 |
| shareCapital: | 1.0000 | totalShareholdersEquity: | 19246.0000 |
| sales: | 28754.0000 | incomeBeforeTaxes: | 690.0000 |
| netIncome: | 480.0000 | cashFlow: | 3906.0000 |
| currencyID: | 4 | units: | 1000000 |
| currency: | USD |
Finanzen (kurz)
| year: | 2022 |
| cash: | 5412.0000 |
| balanceSheetTotal: | 63171.0000 |
| liabilities: | 41962.0000 |
| shareCapital: | 1.0000 |
| totalShareholdersEquity: | 21209.0000 |
| sales: | 27281.0000 |
| incomeBeforeTaxes: | 5814.0000 |
| netIncome: | 4592.0000 |
| cashFlow: | 74.0000 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
| year: | 2023 |
| cash: | 6085.0000 |
| balanceSheetTotal: | 62125.0000 |
| liabilities: | 39376.0000 |
| shareCapital: | 1.0000 |
| totalShareholdersEquity: | 22749.0000 |
| sales: | 27116.0000 |
| incomeBeforeTaxes: | 6859.0000 |
| netIncome: | 5665.0000 |
| cashFlow: | 673.0000 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
| year: | 2024 |
| cash: | 9991.0000 |
| balanceSheetTotal: | 58995.0000 |
| liabilities: | 39749.0000 |
| shareCapital: | 1.0000 |
| totalShareholdersEquity: | 19246.0000 |
| sales: | 28754.0000 |
| incomeBeforeTaxes: | 690.0000 |
| netIncome: | 480.0000 |
| cashFlow: | 3906.0000 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
Finanzen (ausführlich)
| year: | 2023 | units: | 1000000 |
| balanceSheetTotal: | 62125.0000 | cash: | 6085.0000 |
| currentAssets: | 16085.0000 | fixedAssets: | 46040.0000 |
| liabilities: | 11280.0000 | totalLiabilitiesEquity: | 62125.0000 |
| totalShareholdersEquity: | 22749.0000 | property: | 5317.0000 |
| intangibleAssets: | 26454.0000 | longTermInvestments: | 1163.0000 |
| inventories: | 1787.0000 | accountsReceivable: | 4660.0000 |
| accountsPayable: | 550.0000 | liabilitiesTotal: | 39376.0000 |
| longTermDebt: | 23189.0000 | shortTermDebt: | 1798.0000 |
| minorityInterests: | -84.0000 | commonStock: | 1.0000 |
| preferredStock: | 0.0000 | sales: | 27116.0000 |
| netIncome: | 5665.0000 | operatingResult: | 7605.0000 |
| incomeInterest: | -944.0000 | investments: | 5718.0000 |
| incomeTaxes: | -1247.0000 | costGoodsSold: | 6498.0000 |
| grossProfit: | 20618.0000 | minorityInterestsProfit: | 52.0000 |
| cashFlow: | 8006.0000 | cashFlowInvesting: | -2265.0000 |
| cashFlowFinancing: | -5125.0000 | cashFlowTotal: | 673.0000 |
| accountingStandard: | US GAAP | equityRatio: | 36.6181 |
| debtEquityRatio: | 1.0984 | liquidityI: | 0.5395 |
| liquidityII: | 0.9526 | netMargin: | 20.8917 |
| grossMargin: | 76.0363 | cashFlowMargin: | 29.5250 |
| ebitMargin: | 28.0462 | ebitdaMargin: | 0.0000 |
| preTaxROE: | 30.1508 | preTaxROA: | 11.0406 |
| roe: | 24.9022 | roa: | 9.1187 |
| netIncomeGrowth: | 23.3667 | revenuesGrowth: | -0.6048 |
| taxExpenseRate: | -18.1805 | equityTurnover: | 1.1920 |
| epsBasic: | 4.5400 | epsDiluted: | 4.5000 |
| epsBasicGrowth: | 24.0437 | shareCapital: | 1.0000 |
| incomeBeforeTaxes: | 6859.0000 | priceEarningsRatioCompany: | 17.8436 |
| priceCashFlowRatio: | 12.6079 | dividendYield: | 3.7032 |
| bookValuePerShare: | 18.2576 | marketCap: | 100938460000.0000 |
| earningsYield: | 5.6042 | pegRatio: | 0.7421 |
| cashFlowPerShare: | 6.4254 | netAssetsPerShare: | 18.1902 |
| priceBookValueRatio: | 4.4371 | dividendsPerShare: | 3.0000 |
| priceEarningsRatio: | 17.8179 | netEarningsPerShare: | 4.5465 |
| currency: | USD |
| year: | 2024 | units: | 1000000 |
| balanceSheetTotal: | 58995.0000 | cash: | 9991.0000 |
| currentAssets: | 19173.0000 | fixedAssets: | 39822.0000 |
| liabilities: | 12004.0000 | totalLiabilitiesEquity: | 58995.0000 |
| totalShareholdersEquity: | 19246.0000 | property: | 5414.0000 |
| intangibleAssets: | 19948.0000 | longTermInvestments: | 0.0000 |
| inventories: | 1710.0000 | accountsReceivable: | 4420.0000 |
| accountsPayable: | 833.0000 | liabilitiesTotal: | 39749.0000 |
| longTermDebt: | 24896.0000 | shortTermDebt: | 1815.0000 |
| minorityInterests: | -84.0000 | commonStock: | 1.0000 |
| preferredStock: | 0.0000 | sales: | 28754.0000 |
| netIncome: | 480.0000 | operatingResult: | 1662.0000 |
| incomeInterest: | -977.0000 | investments: | 5907.0000 |
| incomeTaxes: | 211.0000 | costGoodsSold: | 6251.0000 |
| grossProfit: | 22503.0000 | minorityInterestsProfit: | 0.0000 |
| cashFlow: | 10828.0000 | cashFlowInvesting: | -3449.0000 |
| cashFlowFinancing: | -3433.0000 | cashFlowTotal: | 3906.0000 |
| accountingStandard: | US GAAP | equityRatio: | 32.6231 |
| debtEquityRatio: | 1.3879 | liquidityI: | 0.8323 |
| liquidityII: | 1.2005 | netMargin: | 1.6693 |
| grossMargin: | 78.2604 | cashFlowMargin: | 37.6574 |
| ebitMargin: | 5.7801 | ebitdaMargin: | 0.0000 |
| preTaxROE: | 3.5852 | preTaxROA: | 1.1696 |
| roe: | 2.4940 | roa: | 0.8136 |
| netIncomeGrowth: | -91.5269 | revenuesGrowth: | 6.0407 |
| taxExpenseRate: | 30.5797 | equityTurnover: | 1.4940 |
| epsBasic: | 0.3800 | epsDiluted: | 0.3800 |
| epsBasicGrowth: | -91.6300 | shareCapital: | 1.0000 |
| incomeBeforeTaxes: | 690.0000 | priceEarningsRatioCompany: | 243.0789 |
| priceCashFlowRatio: | 10.6236 | dividendYield: | 3.3344 |
| bookValuePerShare: | 15.4543 | marketCap: | 115032615746.9400 |
| earningsYield: | 0.4114 | pegRatio: | -2.6528 |
| cashFlowPerShare: | 8.6948 | netAssetsPerShare: | 15.3869 |
| priceBookValueRatio: | 5.9770 | dividendsPerShare: | 3.0800 |
| priceEarningsRatio: | 239.6513 | netEarningsPerShare: | 0.3854 |
| currency: | USD |
| year: | 2025 | priceEarningsRatioCompany: | 293.2632 |
| priceCashFlowRatio: | 12.8169 | dividendYield: | 2.7638 |
| bookValuePerShare: | 15.4543 | marketCap: | 138781365149.2800 |
| earningsYield: | 0.3410 | pegRatio: | -3.2005 |
| cashFlowPerShare: | 8.6948 | netAssetsPerShare: | 15.4543 |
| priceBookValueRatio: | 7.2109 | priceEarningsRatio: | 289.1278 |
| netEarningsPerShare: | 0.3854 | currency: | USD |
Finanzen (ausführlich)
| year: | 2023 |
| units: | 1000000 |
| balanceSheetTotal: | 62125.0000 |
| cash: | 6085.0000 |
| currentAssets: | 16085.0000 |
| fixedAssets: | 46040.0000 |
| liabilities: | 11280.0000 |
| totalLiabilitiesEquity: | 62125.0000 |
| totalShareholdersEquity: | 22749.0000 |
| property: | 5317.0000 |
| intangibleAssets: | 26454.0000 |
| longTermInvestments: | 1163.0000 |
| inventories: | 1787.0000 |
| accountsReceivable: | 4660.0000 |
| accountsPayable: | 550.0000 |
| liabilitiesTotal: | 39376.0000 |
| longTermDebt: | 23189.0000 |
| shortTermDebt: | 1798.0000 |
| minorityInterests: | -84.0000 |
| commonStock: | 1.0000 |
| preferredStock: | 0.0000 |
| sales: | 27116.0000 |
| netIncome: | 5665.0000 |
| operatingResult: | 7605.0000 |
| incomeInterest: | -944.0000 |
| investments: | 5718.0000 |
| incomeTaxes: | -1247.0000 |
| costGoodsSold: | 6498.0000 |
| grossProfit: | 20618.0000 |
| minorityInterestsProfit: | 52.0000 |
| cashFlow: | 8006.0000 |
| cashFlowInvesting: | -2265.0000 |
| cashFlowFinancing: | -5125.0000 |
| cashFlowTotal: | 673.0000 |
| accountingStandard: | US GAAP |
| equityRatio: | 36.6181 |
| debtEquityRatio: | 1.0984 |
| liquidityI: | 0.5395 |
| liquidityII: | 0.9526 |
| netMargin: | 20.8917 |
| grossMargin: | 76.0363 |
| cashFlowMargin: | 29.5250 |
| ebitMargin: | 28.0462 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | 30.1508 |
| preTaxROA: | 11.0406 |
| roe: | 24.9022 |
| roa: | 9.1187 |
| netIncomeGrowth: | 23.3667 |
| revenuesGrowth: | -0.6048 |
| taxExpenseRate: | -18.1805 |
| equityTurnover: | 1.1920 |
| epsBasic: | 4.5400 |
| epsDiluted: | 4.5000 |
| epsBasicGrowth: | 24.0437 |
| shareCapital: | 1.0000 |
| incomeBeforeTaxes: | 6859.0000 |
| priceEarningsRatioCompany: | 17.8436 |
| priceCashFlowRatio: | 12.6079 |
| dividendYield: | 3.7032 |
| bookValuePerShare: | 18.2576 |
| marketCap: | 100938460000.0000 |
| earningsYield: | 5.6042 |
| pegRatio: | 0.7421 |
| cashFlowPerShare: | 6.4254 |
| netAssetsPerShare: | 18.1902 |
| priceBookValueRatio: | 4.4371 |
| dividendsPerShare: | 3.0000 |
| priceEarningsRatio: | 17.8179 |
| netEarningsPerShare: | 4.5465 |
| currency: | USD |
| year: | 2024 |
| units: | 1000000 |
| balanceSheetTotal: | 58995.0000 |
| cash: | 9991.0000 |
| currentAssets: | 19173.0000 |
| fixedAssets: | 39822.0000 |
| liabilities: | 12004.0000 |
| totalLiabilitiesEquity: | 58995.0000 |
| totalShareholdersEquity: | 19246.0000 |
| property: | 5414.0000 |
| intangibleAssets: | 19948.0000 |
| longTermInvestments: | 0.0000 |
| inventories: | 1710.0000 |
| accountsReceivable: | 4420.0000 |
| accountsPayable: | 833.0000 |
| liabilitiesTotal: | 39749.0000 |
| longTermDebt: | 24896.0000 |
| shortTermDebt: | 1815.0000 |
| minorityInterests: | -84.0000 |
| commonStock: | 1.0000 |
| preferredStock: | 0.0000 |
| sales: | 28754.0000 |
| netIncome: | 480.0000 |
| operatingResult: | 1662.0000 |
| incomeInterest: | -977.0000 |
| investments: | 5907.0000 |
| incomeTaxes: | 211.0000 |
| costGoodsSold: | 6251.0000 |
| grossProfit: | 22503.0000 |
| minorityInterestsProfit: | 0.0000 |
| cashFlow: | 10828.0000 |
| cashFlowInvesting: | -3449.0000 |
| cashFlowFinancing: | -3433.0000 |
| cashFlowTotal: | 3906.0000 |
| accountingStandard: | US GAAP |
| equityRatio: | 32.6231 |
| debtEquityRatio: | 1.3879 |
| liquidityI: | 0.8323 |
| liquidityII: | 1.2005 |
| netMargin: | 1.6693 |
| grossMargin: | 78.2604 |
| cashFlowMargin: | 37.6574 |
| ebitMargin: | 5.7801 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | 3.5852 |
| preTaxROA: | 1.1696 |
| roe: | 2.4940 |
| roa: | 0.8136 |
| netIncomeGrowth: | -91.5269 |
| revenuesGrowth: | 6.0407 |
| taxExpenseRate: | 30.5797 |
| equityTurnover: | 1.4940 |
| epsBasic: | 0.3800 |
| epsDiluted: | 0.3800 |
| epsBasicGrowth: | -91.6300 |
| shareCapital: | 1.0000 |
| incomeBeforeTaxes: | 690.0000 |
| priceEarningsRatioCompany: | 243.0789 |
| priceCashFlowRatio: | 10.6236 |
| dividendYield: | 3.3344 |
| bookValuePerShare: | 15.4543 |
| marketCap: | 115032615746.9400 |
| earningsYield: | 0.4114 |
| pegRatio: | -2.6528 |
| cashFlowPerShare: | 8.6948 |
| netAssetsPerShare: | 15.3869 |
| priceBookValueRatio: | 5.9770 |
| dividendsPerShare: | 3.0800 |
| priceEarningsRatio: | 239.6513 |
| netEarningsPerShare: | 0.3854 |
| currency: | USD |
| year: | 2025 |
| priceEarningsRatioCompany: | 293.2632 |
| priceCashFlowRatio: | 12.8169 |
| dividendYield: | 2.7638 |
| bookValuePerShare: | 15.4543 |
| marketCap: | 138781365149.2800 |
| earningsYield: | 0.3410 |
| pegRatio: | -3.2005 |
| cashFlowPerShare: | 8.6948 |
| netAssetsPerShare: | 15.4543 |
| priceBookValueRatio: | 7.2109 |
| priceEarningsRatio: | 289.1278 |
| netEarningsPerShare: | 0.3854 |
| currency: | USD |
